Mosaic Immunoengineering (CPMV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 05-2020 | 05-2019 | 05-2018 | 05-2017 | 05-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 749 | 986 | 2,319 | 1,001 | 1,181 |
| Marketable Securities | N/A | 750 | N/A | 2,203 | 1,956 |
| TOTAL | $785 | $1,790 | $2,327 | $3,317 | $3,153 |
| Non-Current Assets | |||||
| PPE Net | 0 | 1 | 1 | 2 | N/A |
| Investments And Advances | 33 | 108 | 199 | 442 | 671 |
| Other Non-Current Assets | 0 | 26 | 52 | 0 | 0 |
| TOTAL | $33 | $135 | $253 | $444 | $671 |
| Total Assets | $819 | $1,925 | $2,580 | $3,761 | $3,823 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2 | 9 | 45 | 14 | 33 |
| Accrued Expenses | 180 | 219 | 40 | 43 | 40 |
| TOTAL | $183 | $228 | $85 | $57 | $74 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $183 | $228 | $85 | $57 | $74 |
| Shareholders' Equity | |||||
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -62,187 | -61,126 | -60,328 | -59,118 | -59,073 |
| Other shareholders' equity | 374 | 374 | 374 | 374 | 374 |
| TOTAL | $636 | $1,697 | $2,495 | $3,705 | $3,750 |
| Total Liabilities And Equity | $819 | $1,925 | $2,580 | $3,761 | $3,823 |